These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14674207)

  • 1. Is antenatal antibody screening worthwhile in the Zimbabwean population?
    Cakana AZ; Ngwenya L
    Cent Afr J Med; 2000 Feb; 46(2):38-41. PubMed ID: 14674207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and outcome of clinically significant antibodies detected in Rhesus-D positive pregnant women of the Northern Territory.
    Andersson L; Szabo F
    Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):514-517. PubMed ID: 29192961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden.
    Filbey D; Hanson U; Wesström G
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):687-92. PubMed ID: 7572101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
    Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
    Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
    BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is antenatal antibody screening worthwhile in Chinese?
    Wong KF; Tse KT; Lee AW; Mak CS; So CC
    Br J Haematol; 1997 Jun; 97(4):917-9. PubMed ID: 9217197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990.
    Hughes RG; Craig JI; Murphy WG; Greer IA
    Br J Obstet Gynaecol; 1994 Apr; 101(4):297-300. PubMed ID: 8199074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
    Craig S; Morris K; Tubman T; McClure B
    Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and clinical significance of red cell antibodies in pregnancy - A prospective study from India.
    Das S; Shastry S; Rai L; Baliga PB
    Indian J Pathol Microbiol; 2020; 63(2):241-246. PubMed ID: 32317523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].
    van der Ploeg CP; Hirschberg HJ; de Haas M; Abbink F
    Ned Tijdschr Geneeskd; 2015; 159():A8315. PubMed ID: 25898866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of haemolytic disease of the newborn in Harare, Zimbabwe.
    Mandisodza AR; Mangoyi G; Musekiwa Z; Mvere D; Abayomi A
    West Afr J Med; 2008 Jan; 27(1):29-31. PubMed ID: 18689300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.
    Tiblad E; Taune Wikman A; Ajne G; Blanck A; Jansson Y; Karlsson A; Nordlander E; Holländer BS; Westgren M
    PLoS One; 2013; 8(8):e70984. PubMed ID: 23940682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.
    Szczepura A; Osipenko L; Freeman K
    BMC Pregnancy Childbirth; 2011 Jan; 11():5. PubMed ID: 21244652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Howard HL; Martlew VJ; McFadyen IR; Clarke CA
    Br J Obstet Gynaecol; 1997 Jan; 104(1):37-41. PubMed ID: 8988694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of pregnancy complicated by anti-hrB/anti-HrB.
    Win N; Needs M; Tillyer L
    Immunohematology; 2007; 23(4):143-5. PubMed ID: 18284303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience.
    Moncharmont P; Juron Dupraz F; Vignal M; Rigal D; Meyer F; Debeaux P
    Arch Gynecol Obstet; 1991; 248(4):175-80. PubMed ID: 1910321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is antenatal antibody screening worthwhile in the Zimbabwean population?
    Verkuyl DA
    Cent Afr J Med; 2001 Jan; 47(1):26-8; author reply 28. PubMed ID: 11961856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.